Your browser doesn't support javascript.
loading
A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins.
Kierzek, Andrzej M; Hickling, Timothy P; Figueroa, Isabel; Kalvass, J Cory; Nijsen, Marjoleen; Mohan, Krithika; Veldman, Geertruida M; Yamada, Akihiro; Sayama, Hiroyuki; Yokoo, Sachiko; Gulati, Abhishek; Dhanikula, Renu S; Gokemeijer, Jochem; Leil, Tarek A; Thalhauser, Craig J; Giorgi, Mario; Swat, Maciej J; Chelliah, Vijayalakshmi; Small, Ben G; Benson, Neil; Walker, Michael; Gadkar, Kapil; Quarmby, Valerie; Deng, Rong; Ferrante, Andrea; Dickinson, Gemma L; Van Der Walt, Jan-Stefan; Zhou, Lian; Chen, Xiaoying; Jones, Hannah M; Narula, Jatin; Tourdot, Sophie; Lavé, Thierry; Ribba, Benjamin; van der Graaf, Piet H.
Afiliação
  • Kierzek AM; Certara QSP, Certara UK Limited, Sheffield, UK.
  • Hickling TP; BioMedicine Design, Pfizer, Andover, Massachusetts, USA.
  • Figueroa I; AbbVie Inc, North Chicago, Illinois, USA.
  • Kalvass JC; AbbVie Inc, North Chicago, Illinois, USA.
  • Nijsen M; AbbVie Inc, North Chicago, Illinois, USA.
  • Mohan K; AbbVie Inc, North Chicago, Illinois, USA.
  • Veldman GM; AbbVie Inc, North Chicago, Illinois, USA.
  • Yamada A; Pharmacometrics JP, Clinical Pharmacology and Exploratory Development, Astellas Pharma Inc., Tokyo, Japan.
  • Sayama H; Analysis & Pharmacokinetics Research Labs, Astellas Pharma Inc., Tsukuba-shi, Japan.
  • Yokoo S; Analysis & Pharmacokinetics Research Labs, Astellas Pharma Inc., Tsukuba-shi, Japan.
  • Gulati A; Pharmacometrics US, Clinical Pharmacology and Exploratory Development, Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.
  • Dhanikula RS; Bristol-Myers Squibb, Princeton, New Jersey, USA.
  • Gokemeijer J; Bristol-Myers Squibb, Princeton, New Jersey, USA.
  • Leil TA; Bristol-Myers Squibb, Princeton, New Jersey, USA.
  • Thalhauser CJ; Bristol-Myers Squibb, Princeton, New Jersey, USA.
  • Giorgi M; Certara QSP, Certara UK Limited, Sheffield, UK.
  • Swat MJ; Certara QSP, Certara UK Limited, Sheffield, UK.
  • Chelliah V; Certara QSP, Certara UK Limited, Canterbury, UK.
  • Small BG; Certara QSP, Certara UK Limited, Sheffield, UK.
  • Benson N; Certara QSP, Certara UK Limited, Canterbury, UK.
  • Walker M; Certara QSP, Certara UK Limited, Sheffield, UK.
  • Gadkar K; Development Sciences, Genentech, San Francisco, California, USA.
  • Quarmby V; Development Sciences, Genentech, San Francisco, California, USA.
  • Deng R; Development Sciences, Genentech, San Francisco, California, USA.
  • Ferrante A; AME Biotechnology Discovery Research, Lilly Biotechnology Center, San Diego, California, USA.
  • Dickinson GL; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Van Der Walt JS; Eli Lilly Research & Development, Windlesham, UK.
  • Zhou L; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Chen X; BioMedicine Design, Pfizer, Cambridge, Massachusetts, USA.
  • Jones HM; BioMedicine Design, Pfizer, Cambridge, Massachusetts, USA.
  • Narula J; BioMedicine Design, Pfizer, Cambridge, Massachusetts, USA.
  • Tourdot S; BioMedicine Design, Pfizer, Andover, Massachusetts, USA.
  • Lavé T; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.
  • Ribba B; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.
  • van der Graaf PH; Certara QSP, Certara UK Limited, Canterbury, UK.
CPT Pharmacometrics Syst Pharmacol ; 8(11): 773-776, 2019 11.
Article em En | MEDLINE | ID: mdl-31529677

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Biologia de Sistemas Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Biologia de Sistemas Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article